NEWS & MEDIA
Recent ivWatch Coverage
Write up on the ivWatch Funding Announcement
Drug Delivery Business News
Overview of ivWatch Funding Announcement
ivWatch President & CEO answers questions about the company related to the ivWatch Funding Annnouncement
Third Party Press Release
MDEA Award Ceremony and full winner’s list
Medical Design & Outsourcing
Additional story around the ivWatch OEM board announcement
HAMPTON, Va. — June 14, 2017 — ivWatch LLC, a medical device company focused on improving the safety and effectiveness of intravenous (IV) therapy, is pleased to announce it was the Bronze Winner last night in the category of Nonsurgical Hospital Supplies and Equipment at the 2017 Medical Design Excellence Awards (MDEAs), the premier awards program for the medtech industry. The award was presented by Medical Device and Diagnostics Industry magazine at the Jacob K. Javits Center in New York during MD&M East, the largest annual medical technology conference on the East Coast for the medical manufacturing industry.
“It’s an honor for ivWatch to be recognized by the MDEA judges for the outstanding design of our device,” said Gary P. Warren, ivWatch president and CEO. “IV infiltration is a major problem for the medical community as it can lead to serious medical complications and even amputation. Our team of employees, partners and suppliers are committed to solving this problem, and have worked tirelessly to make a significant impact in minimizing patient harm from infiltrations.”
The ivWatch Model 400 continuously monitors a patient’s peripheral IV for evidence of infiltrations, which occur when medication or fluid leaks into the surrounding tissue. Intravenous therapy is a routine part of treatment for nearly 80 percent of patients in the U.S., yet more than 20 percent of these IVs may fail because of infiltration, risking both a serious drug delivery error and tissue damage. Earlier detection of those failures, via ivWatch sensor technology, is the new and next step in minimizing this potential for injury.
MDEA is the medtech industry’s premier manufacturing design competition, recognizing the highest caliber of commercially available products approved by the FDA or other regulating bodies. These awards celebrate the achievements of medical device manufacturers, their suppliers, and the teams behind the scenes who provide input and dedication to innovative products, further improving patient safety across healthcare today.
ivWatch LLC is a medical device manufacturer focused on improving patient safety and the effectiveness of intravenous therapy. With the Model 400, which is similar to continuous monitors available for a patient’s heart, blood oxygen level and pulse, ivWatch provides a first-of-its-kind, FDA-cleared, noninvasive medical device that continuously monitors peripheral IVs for infiltration and extravasation events. The ivWatch Model 400 aims to help eliminate patient harm associated with adverse events and to reduce drug delivery errors. The ivWatch OEM Board integrates ivWatch technology into existing products, enabling OEMs to help healthcare customers deliver a higher level of patient care and to reduce risks related to IV therapy. Follow us on Twitter@ivWatch or Facebook @ivWatchLLC. www.ivWatch.com
MEDIA CONTACT: Leah Moore, email@example.com, Office (855) 489-2824 x7031, Mobile (757) 839-5653
The ivWatch OEM Board is not an FDA-cleared device. It is the responsibility of the Original Equipment Manufacturer integrating ivWatch technology to secure the proper regulatory clearance.
ivWatch company and product information is available. If you would like more information, please contact us at firstname.lastname@example.org with your request.
Press kit: Download
ivWatch Monitored PIV Infographic: Download
ivWatch Patient Safety Infographic: Download
ivWatch Company Brochure: Download
ivWatch Pediatric Brochure: Download
Model 400 Fact Sheet: Download
Model 400 Product Manual: Download
OEM Tech Sheet: Download
For media inquiries, please contact:
ivWatch Director, Marketing
855-489-2824 ext. 7031